Literature DB >> 34919261

The preoperative evaluation of post-COVID-19 patients scheduled for elective surgery - What is important not to miss!

M Tunescu1, R Christodorescu, A Sharma, C R Barsac, A F Rogobete, D C Crisan, S E Popovici, N R Kundnani, D Sandesc, O Bedreag.   

Abstract

Continuous rise in the number of COVID-19 cases, since it was first diagnosed in 2019, forced the entire medical fraternity to delay elective surgeries. The preoperative evaluation guidelines that were used in the pre-COVID-19 era underwent significant changes, adding modifications to meet the post-COVID patients' specific criteria and requirements. Currently, all patients before or at the time of hospital admission were tested using a nasopharyngeal swab, by RT-PCR for SARS-CoV-2. Apart from this, for a patient undergoing elective surgery in their post-COVID-19 period, it is mandatory to obtain a detailed history of COVID-19 disease/SARS-CoV-2 infection, to identify residual symptoms or any organ dysfunction the infection might have caused. As well as the functional optimization of the patient to achieve the best clinical and biological status before the surgery. After all the systems have been thoroughly investigated, the risk-benefit ratio needs to be calculated, keeping in mind the cytokine storm and inflammatory responses encountered postoperatively. A mere negative RT-PCR test cannot be considered as the only decisive factor to operate, as the post-COVID-19 phase can influence postoperative outcome of the patient. Hence, the pre-operative evaluation protocols of post-COVID patients should be set and followed thoroughly, in order to avoid post-surgical complications. For better surgical and post-surgical management of post-COVID-19 patients, conducting clinical tests, assessing previously administered medications, evaluating the need for deep venous thrombosis prophylaxes, and identifying subclinical inflammatory state are the measures that should be taken.

Entities:  

Mesh:

Year:  2021        PMID: 34919261     DOI: 10.26355/eurrev_202112_27459

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  1 in total

1.  COVID-19 and the Human Eye: Conjunctivitis, a Lone COVID-19 Finding - A Case-Control Study.

Authors:  Valeria Mocanu; Dharmesh Bhagwani; Abhinav Sharma; Claudia Borza; Ciprian Ilie Rosca; Morariu Stelian; Shalini Bhagwani; Laura Haidar; Lajwanti Kshtriya; Nilima Rajpal Kundnani; Florin-Raul Horhat; Raluca Horhat
Journal:  Med Princ Pract       Date:  2022-01-05       Impact factor: 1.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.